The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

Glucagon-like peptide 1 receptor agonists, which are found in Ozempic-like drugs, can could cause devastating symptoms in ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

The General Inspectorate of Health Activities (IGAS) has opened a clarification process regarding the marketing of the drug ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Semaglutide, the active ingredient in these drugs, is the latest in this class of GLP-1 agonists. Liraglutide (Saxenda) has been on the market for years, but it did not generate the same kind of ...

However, liraglutide’s comparative weight loss efficacy is important to consider. A 2022 study compared semaglutide and liraglutide head-to-head. It was found that those taking liraglutide lost ...

While several molecules are available in the anti-obesity segment, data shows semaglutide pill Rybelsus ... dulaglutide (market value `72 crore) and liraglutide (market value `34 crore).

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

Share on Pinterest Common antidiabetes drugs could help lower Alzheimer’s risk, increasing evidence suggests. Image credit: mbbirdy/Getty Images. A new study investigates the relationship ...